Delivery Order SPE2DB20D2014-SPE2DB25FD17Q
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,403.57 to AmerisourceBergen Drug Corp for supply of Januvia 50 mg tablets (90-count) with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical product will be delivered to the vendor's corporate headquarters location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count) valued at $1,122.26 under a firm fixed price contract. This delivery order, issued on August 27, 2025, with completion scheduled for August 28, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made through competitive procurement with no set-aside designation, and the product will be delivered to the...
- The Defense Logistics Agency awarded a $2,654.77 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,413.42 for Januvia 50 mg tablets (90-count units) on October 15, 2025, with completion expected by October 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Januvia 100 mg tablets in quantities of 90s, valued at $1,584.99. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,911.57 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, and represents a non-set-aside, competitively awarded procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.44 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count packages) under a firm fixed price contract type. The award, dated September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,665.83 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on December 18, 2025, with completion scheduled for December 19, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract is classified as a child award under AmerisourceBergen's broader relationship with the federal government and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $2,517.06. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be completed by November 19, 2025, and the pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Januvia 50 mg tablets (90-count units) at a ceiling value of $3,252.65. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This delivery order is a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD17QDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,365.84 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) on September 29, 2025, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical delivery under AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive contract vehicle enabling it to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/29/25 |